Sky Labs (CEO Jack Byunghwan Lee) announced on the 3rd that it introduced its data platform business at the 9th Digital Biomarkers in Clinical Trials Summit in Basel, Switzerland, highlighting the potential of its ring-type cuffless blood pressure monitor, 'CART BP pro,' for clinical trials and Real-World Evidence (RWE) data.
The summit is an international event where multinational pharmaceutical companies, clinical trial experts, and digital healthcare enterprises gather to discuss innovative methods for clinical trials leveraging wearable devices and digital health technologies. This year's event, held in Basel—home to Roche's headquarters—attracted approximately 350 attendees, including Roche and Novartis.
Leveraging this event, Sky Labs strategises to position itself as a core partner in supporting drug clinical trials for global pharmaceutical companies by providing high-quality vital signs data collected based on patient consent. In South Korea, the platform's utility as a data platform is already being validated in state-led research, having been adopted for a large-scale cohort study managed by the National Institutes of Health (NIH) under the Korea Disease Control and Prevention Agency (KDCA).
Presenting at the summit, Sky Labs shared real-world achievements and highlighted CART BP pro’s value as a clinical data platform. In particular, the company drew significant attention from the audience by addressing the critical limitations of conventional cuff-type 24-hour ambulatory blood pressure monitoring (ABPM) devices widely used in clinical trials. The arm-constricting cuff-type devices disrupt sleep and cause discomfort for subjects during nighttime measurements, which increases dropout rates, drives up costs, and delays clinical timelines. In fact, according to a study (Viera et al., 2011), 70.2 per cent of conventional ABPM users experienced sleep disruption caused by the device awakening them. Furthermore, within the participant group with low tolerability, the failure rate for collecting adequate 24-hour data increased significantly to 50.0 per cent during repeated measurements.
Conversely, CART BP pro is a ring-type cuffless blood pressure monitor worn on the finger, capable of collecting blood pressure data during daily activities and sleep without repeated arm constriction. This significantly alleviates the measurement burden on subjects and contributes to securing stable, long-term vital signs data, including blood pressure and heart rate.
In addition, CART BP pro can be utilised not only in the drug development phase but also in evaluating therapeutic responses to conventional medications already on the market. By continuously monitoring blood pressure fluctuations based on dosing times, dosages, and lifestyle patterns, the device helps secure the necessary Real-World Evidence (RWE) data for evaluating drug efficacy, safety, and patient prognosis.
